Pathology, natural history and treatment of abdominal aortic aneurysms

Clinical Research in Cardiology

Volumn 96, Issue 3, 2007, Pages 140-151

  Zankl, A R ^a   Schumacher, H ^a   Krumsdorf, U ^a   Katus, H A ^a   Jahn, L ^a   Tiefenbacher, Christiane P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aneurysm; Aorta; Endovascular treatment; Rupture; Surgery

Indexed keywords

BATIMASTAT; CERIVASTATIN; DOXYCYCLINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROPRANOLOL DERIVATIVE; TETRACYCLINE;

ABDOMINAL AORTA ANEURYSM; CHRONIC INFLAMMATION; CLINICAL FEATURE; DISEASE COURSE; ELECTIVE SURGERY; ENDOVASCULAR SURGERY; HUMAN; INCIDENCE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; VACCINATION;

ADRENERGIC BETA-ANTAGONISTS; AORTIC ANEURYSM, ABDOMINAL; DRUG THERAPY, COMBINATION; GERMANY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MASS SCREENING; PREVALENCE; PROTEASE INHIBITORS; RISK FACTORS; SURVIVAL ANALYSIS; TETRACYCLINES; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 33847674081     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-007-0472-5     Document Type: Review

References (99)

1. Sakalihasan N, Limet R, Defawe OD (2005) Abdominal aortic aneurysm. Lancet 365:1577-1589
2. Multicentre Aneurysm Screening Study Group (2002) Multicentre aneurysm screening study (MASS): cost effectivenss analysis of screening for abdominal aortic aneurysm based on four year results from randomised controlled trial BMJ 325:1135-1138
3. National Hospital Discharge Survey Data (2002) Hyattsville, Md: National Center for Health Statistics
4. Isselbacher EM (2004) Diseases of the aorta. In: Braunwald E, Zipes DP, Libby P, Bonour RO (eds) Braunwald's heart disease. Saunder Philadelphia, pp 1403-1404
5. Liddington MI, Healther BP (1992) The relationship aortic diameter and body habitus. Eur J Vasc Surg 6:89-92
6. Johnston KW, Rutherford RB, Tilson MD, Shah DM, Hollier L, Stanley JC (1991) Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 13:452-458
7. Singh K, Bonaa KH, Jacobsen BK, Bjork L, Solberg S (2001) Prevalence and risk factors for abdominal aortic aneurysms in a population-based study: the Tromso Study. Am J Epidemiol 154:236-244
8. Liddington MI, Heather BP (1992) The relationship between aortic diameter and body habitus. Eur J Vasc Surg 6:89-92
9. Schumacher H, Eckstein HH, Kallinowski F, Allenberg JR (1996) Morphometry and classification in abdominal aortic aneurysms. J Endovasc Surg 4:39-44
10. Jonasson L, Holm J, Skalli O, Bondjiers G, Hansson GK (1986) Regional accumulations of T cells, marcorphages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6:131-138
11. Herron GS, Unemori E, Wong M, Rapp JH, Hibbs MH, Stoney RJ (1991) Connective tissue proteinases and inhibitors in abdominal aortic aneurysms: involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb 11:1667-1677
12. Homes DR, Liao S, Parks WC, Thompson RW (1995) Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurismal degeneration with pathophysiological implications. J Vasc Surg 21:761-771
13. Shah PK (1997) Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 96:2115-2117
14. Curci JA, Lee JK, Thompson RW (2001) Pathogenesis of abdominal aortic aneurysm. In: Ernst CB, Stanley JC (eds) Current Therapy in Vascular Surgery. Elsevier, Philadelphia, pp 199-206
15. MacSweeney STR, Powell JT, Greenhalgh RM (1994) Pathogenesis of abdominal aortic aneurysm. Br J Surg 81:935-941
16. Van der Vliet J A, Boll APM (1997) Abdominal aortic aneurysm. Lancet 349:863-866
17. Satta J, Juvonen T, Haukipuro K, Juvonen M, Kairaluoma MI (1995) Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. J Vasc Surg 22:155-160
18. Huffman MD, Curci JA, Moore G, Kerns DB, Starcher BC, Thompson RW (2000) Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery 128:429-438
19. Dobrin PB, Mrkvicka R (1994) Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 2:484-488
20. Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A (2000) Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105:477-482
21. Defawe OD, Colige A, Lambert CA et al (2003) TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc Res 60:205-213
22. Rao SK, Reddy KV, Cohen JR (1996) Role of serine proteases in aneurysm development. Ann NY Acad Sci 800:131-137
23. Thompson RW, Parcs WC (1996) Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann NY Acad Sci 800: 157-174
24. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT (2002) Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110:625-632
25. Shi G-P, Sukhova GK, Grubb A (1999) Cystatin C deficiency in human atherosclerosis and aortic aneurysms J Clin Invest 104:1191-1997
26. Zhao L, Moos PW, Gräbner R, Pedrono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, Lotzer K, Huang L, Cui J, Rader DJ, Evans JF, Hebnicht AJ, Funk CD (2004) The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nature 9:966-973
27. Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW (1997) Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 150:993-1007
28. Allaire E, Muscatelli-Groux B, Mandet C et al (2002) Paracrine effect of vascular smooth muscle cells in the prevention of aortic aneurysm formation. J Vasc Surg 36:1018-1026
29. Vorp DA, Lee PC, Wang DH et al (2001) Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and walk weakening. J Vasc Surg 43:291-299
30. Sakalihasan N, Delvenne P, Nusgens BV, Limet R, Lapiere CM (1996) Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 24:127-133
31. Fontaine V, Jacob MP, Houard X et al (2002) Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161:1701-1710
32. Havanna KK, Eliason JL, Woodrum DT et al (2005) L-Selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation 112:241-247
33. Jones K, Powell J, Brown L, Greenhalgh R, Jormsjo S, Eriksson P (2002) Influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promotor on the incidence, growth and operative risk of abdominal aortic aneurysm. Eur. J Vasc Endovasc Surg 23:421-425
34. Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J (2003) LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300:329-332
35. Lederle, FA, Johnson GR, Wilson SE et al (2000) The aneurysm detection and mangement study screening program: validation cohort and final results. Arch Intern Med 160:1425-1430
36. Lindholdt JS, Vammen S, Juul S, Fasting H, Henneberg EW (2000) Optimal interval screening and surveillance of abdominal aortic aneurysms. Eur J Vasc Endovasc 20:369-373
37. Vardulaki KA, Walker NM, Day NE, Duffy W, Ashton HA, Scott RA (2000) Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg 87:195-200
38. Pleumeekers HJCM, Hoes AW, van der Does E et al (1995) Aneurysms of the abdominal aorta in older adults; the Rotterdam study. Am J Epidemiol 142: 1291-1299
39. Simoni G, Pastorino C, Perrone R, Ardia A, Gianrossi R, Decian F (1995) Screening for abdominal aortic aneurysms and associated risk factors in a general population. Eur J Vasc Endovasc Surg 10:207-210
40. Lederle FA, Johnson GR, Wilson SE (1997) Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detections and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med 126(6):441-449
41. Brown LC, Powell JT (1999) Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants. Ann Surg 230:289-296; discussion 296-297
42. Blanchard JF, Armenian HK, Friesen PP (2000) Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 151:575-583
43. Lindholt JS, Heegaard NH, Vammen S, Fasting H, Henneberg EW, Heickendorff L (2001) Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneuysms. Eur J Vasc Endovasc Surg 21:51-56
44. Wilmink TBM, Quick CRG, Day NE (1999) The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg 30:1099-1105
45. Davies MJ (1998) Aortic aneurysm formation: lessons from human studies and experimental models. Circulation 98:193
46. Vardulaki KA, Prevost TC, Walker NM, Day NE, Wilmink AB, Quick CR, Ashton HA, Scott RA (1998) Growth rate and risk of rupture of abdominal aoric aneurysms. Br J Surg 85:1674-1680
47. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT (2004) Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 110:16-21
48. MacSweeney STR, Ellis M, Worrell PC, Greenhalgh RM, Powell JT (1994) Smoking and growth rate of small abdominal aortic aneurysms. Lancet 344:651-652
49. Moran CS, McCann M, Karan M, Norman P, Ketheesan N, Golledge J (2005) Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 111(23):3119-3125
50. Newman AB, Shemanski L, Manolio TA et al (1999) Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19:538-545
51. Gacko M, Chyczewski L (1997) Activity and localization of cathepsin B, D, and G in aortic aneurysm. Int Surg 82(4):398-402
52. Portik-Dobos V, Anstat MP, Hutchinson J et al (2002) Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes. Diabetes 51:3036-3068
53. Mehard WB, Heiken JP, Sicard GA (1994) High-attenuating crescent in abdominal aortic aneurysm wall at CT: a sign of acute or impending rupture. Radiology 192:359-362
54. Siegel CL, Cohan RH, Korobkin M, Alpern MB, Courneya DL, Leder RA (1994) Abdominal aortic aneurysm morphology: CT features in patients with ruptured and nonruptured aneurysms. AJR Am J Roentgenol 163:1123-1129
55. Arita T, Matsunaga N, Takano K et al (1997) Abdominal aortic aneurysm: rupture associated with the high-attenuating crescent sign. Radiology 204:765-768
56. Sakalihasan N, Van Damme H, Gomez P et al (2002) Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg 23:431-436
57. Elzouki AN, Ryden Ahlgren A, Lanne T, Sonesson B, Eriksson S (1999) Is there a relationship between abdominal aortic aneurysms and alpha1-antitrypsin deficiency (PiZ)? Eur J Vasc Endovasc Surg 17:149-154
58. Limet R, Sakalihasan N, Albert A (1991) Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg 14):540-548
59. Muluk SC, Gertler JP, Brewster DC et al (1994) Presentations and patterns of aortic aneuryms in young patients. J Vasc Surg 20:880
60. Kiell CS, Ernst CB (1993) Advances in the management of abdominal aortic aneurysms. Dv Surg 26:73
61. Tang T, Wai-Leng C, Munday I, Gaunt M (2005) Ruptured abdominal aortic aneurysm. Lancet 365(9461):818
62. Abrurahma AF, Woodruff BA, Stuart SP, Lucente FC, Boland JP (1991) Early diagnosis and survival of ruptured abdominal aoric aneurysms. Am J Emerg Med 9(2):118-121
63. Parry DJ, Waterworth A, Kessel D, Robertson I, Berridge DC, Scott DJ (2001) Endovascular repair of an inflammatory abdominal aortic aneurysm complicated by aortoduodenal fistulation with an unusual presentation. J Vasc Surg 33:874-879
64. Kane JM, Meyer KA, Kozoll DD (1955) An anatomical approach to the problem of massive gastrointestinal hemorrhag. AMA Arch Surg 70:570-582
65. Hirst AE Jr, Affeldt J (1951) Abdominal aortic aneurysm with rupture into the duodenum; a report of eight cases. Gastroenterol 17:504-514
66. Lemos DW, Raffetto JD, Moore TC, Menzoian JO (2003) Primary aortoduodenal fistula: a case report and review of the literature. J Vasc Surg 37:686-689
67. Davis PM, Gloviczki P, Cherry KJ Jr et al (1998) Aorto-caval and ilio-iliac arteriovenous fistulae. Am J Surg 176: 115-118
68. Lederle FA, Walker JM, Reinke DB (1988) Selective screening for abdominal aortic aneuryms with physical examination and ultrasound. Arch Intern Med 148:1753-1756
69. Beede SD, Ballard DJ, James EM, Ilstrup DM, Hallet JW Jr (1990) Positive predictive value of clinical suspicion of abdominal aortic aneurysm. Implications for efficient use of abdominal ultrasonography. Arch Intern Med 150(3): 549-551
70. Lindholt JS, Vammen S, Juul S, Henneberg EW, Fasting H (1999) The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 17(6):472-775
71. Crow P, Shaw E, Earnshaw JJ, Poskitt KR, Whyman MR, Heather BP (2001) A single normal ultrasonographic scan at age 65 years rules out significant aneurysm disease for life in men. Br J Surg 88:941-944
72. Scott RAP, Vardulaki KA, Walker NM, Day NE, Duffy W, Ashton HA (2001) The longterm benefits of a single scan for abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Eur J Vasc Endovasc Surg 21: 535-540
73. Frydman G, Walker PJ, Summers K et al (2003) The value of screening in siblings of patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 26:396-400
74. Silence J, Lupu F, Collen D, Lijnen HR (2001) Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Atheroscler Thromb Vasc Biol 1440-1445
75. Powell JT, Greenhalgh RM (2003) Clinical practice. Small abdominal aortic aneurysms. N Engl J Med 348(19): 1895-1901
76. The UK Small Aneurysm Trial Participants (1998) Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 352:1649-1655
77. The United Kingdom Small Aneurysm Trial Participants (2002) Long-term outcomes of immediate repair compared with surveillance for small abdominal aortic aneurysm. N Engl J Med 346:1445-1452
78. Ashton HA, Buxton MJ, Day NE et al (2002) The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality on men: a randomised controlled trial. Lancet 360: 1531-1539
79. Parodi JC, Palmaz JC, Barone HD (1991) Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 5:491-499
80. Prinssen M, Verhoeven EL, Buth J et al (2004) A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 351:1607-1618
81. Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG; EVAR trial participants (2004) Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operativ mortality results: randomied controlled trial. Lancet 364:843-848
82. Hallet JW Jr, Marshall DM, Petterson TM et al (1997) Graft-related complications after abdominal artic aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg 25:277-284; discussion 285-286
83. Johnston KW (1994) Nonruptured abdominal aortic aneurysm: six-year follow-up results from the mulicenter prospective Canadian aneurysm study. J Vasc Surg 20:163-170
84. Lederle FA, Wilson ES, Johnson GR et al (2002) Immediate repair compared with surveillance of small aortic abdominal aneurysms. N Engl J Med 346:1437-1444
85. Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG; EVAR trial participants (2005) Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 365:2179-2186
86. Blankensteijn JD, de Jong SECA, Prinsson M, van der Ham AC, Buth J, van Sterkenburg SMM, Verhagen HJM, Buskens E, Grobbee DE for the Dutch Randomised Endovascular Aneurysm Management (DREAM) (2005) Trial Group N Engl J Med 352:2398-2405
87. Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG; EVAR trial participants (2005) Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet 365:2187-2192
88. Curci JA, Petrinec D, Liao S, Golub LM, Thompson RW (1998) Pharmacological suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg 28:1082-1093
89. Bigatel DA, Elmore JR, Carey DJ, Cizmeci-Smith G, Franklin DP, Youkey JR (1999) The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J Vasc Surg 29:130-138; discussion 138-139
90. Moore G, Liao S, Curci JA et al (1999) Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). J Vasc Surg 29:522-532
91. Takemoto M, Liao JK (2001) Pleiotropic effects of 3-hydroxy-3- methylglutary coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 21: 1712-1719
92. Crisby M, Nordin-Fredriksson G, Sha PK, Yano J, Zhu J, Nilsson J (2001) Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103:926-933
93. Sposito AC, Chapman MJ (2002) Statin therapy in acute coronary syndromes; mechanistic insight into clinical benefit. Arterioscer Thromb Vasc Biol 22:1524-1534
94. Kwak B, Mulhaupt F, Myit S, Mach F (2000) Statins as a newly recognized type of immunomodulator. Nat Med 6:1399-1402
95. Kertai MD, Boersma E, Westerhout CM et al (2004) Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 116:96-103
96. Nagashima H, Aoka Y, Sakomura Y et al (2002) A 3-hydroxy-3-methylglutaryl coenzyme. A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg 26:158-163
97. Gadowski GR, Pilcher DB, Ricci MA (1994) Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg 19: 727-731
98. Slaiby JM, Ricci MA, Gadowski GR, Hendley ED, Pilcher DB (1994) Expansion of aortic aneurysms is reduced by propanolol in a hypertensive rat model. J Vasc Surg 20:178-183
99. Nilsson J, Hansson GK, Shah PK (2005) Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler Thromb Vasc Biol 25:18-28